EVIO announced the closing of its previously announced acquisition of 50 percent stake in Keystone Labs.
EVIO (OTCQB:EVIO) announced the closing of its previously announced acquisition of 50 percent stake in Keystone Labs, a Canadian cannabis testing facility
As quoted in the press release:
“We are excited to have completed this transaction and add Keystone Labs to our portfolio,” said William Waldrop, CEO of EVIO. “In Canada, cannabis is federally legal, however, there is a limited number of testing facilities licensed to provide services. Keystone Labs has been licensed for two years, has a strong management team, and we are confident that we can leverage our background and deployment strategies to capture significant market share.”